Applied Pharmaceutical Innovation Appoints Dr. Launa Aspeslet as Chief Translational Officer to Accelerate Life Sciences Commercialization in CanadaEDMONTON, Alberta, May 13, 2025 (GLOBE NEWSWIRE) -- Applied Pharmaceutical Innovation (API), one of Canada’s leading life sciences commercialization organizations, is proud to announce the appointment of Dr. Launa Aspeslet as its first Chief Translational Officer.
API and the University of Alberta Break Ground in Edmonton on Canada’s Largest Manufacturing Facility for Critical MedicinesEDMONTON, Alberta, June 20, 2024 (GLOBE NEWSWIRE) -- Construction is set to begin on a crucial pharmaceutical manufacturing facility in the Edmonton Research Park that will provide Canadians with access to a stable supply of high-demand, critical drugs at the most difficult of times.
